Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
CU-06 by Thea Open Innovation SASU for Diabetic Macular Edema: Likelihood of Approval
CU-06 is under clinical development by Thea Open Innovation SASU and currently in Phase II for Diabetic Macular Edema. According...